Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo
THURSDAY, Oct. 20, 2022 (HealthDay News) — For patients with vitiligo, ruxolitinib cream results in greater repigmentation of lesions compared with vehicle control, according to a study published online Oct. 20 in the New England Journal of Medicine….
Learn MoreStudy Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial s…
Learn MoreStudy Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial s…
Learn MoreFDA Panel Votes for Removal of Drug Meant to Prevent Preterm Births
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — A U.S. Food and Drug Administration advisory committee on Wednesday voted to recommend that a controversial drug meant to prevent premature births be pulled from the market.FDA officials have said they want…
Learn MorePhosphodiesterase-5 Inhibitors Not Tied to Alzheimer Disease Risk
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia, according to a study published online Oct. 4 in Brain Communications.Rishi J. …
Learn MoreFDA, Company Square Off in Hearing Over Drug Meant to Prevent Preterm Births
TUESDAY, Oct. 18, 2022 (HealthDay News) — In a three-day hearing that began Monday, a U.S. Food and Drug Administration advisory committee will give the maker of a drug meant to prevent premature births a chance to show why its drug should not be pul…
Learn MoreMajor Trial of Monkeypox Treatment TPOXX to Launch in Africa
MONDAY, Oct. 17, 2022 (HealthDay News) — The ability of TPOXX to treat people infected with monkeypox is being directly tested in a new clinical trial in Central Africa, U.S. health officials have announced.TPOXX — the antiviral drug tecovirimat — …
Learn MoreLa FDA advierte que Adderall, un fármaco para el TDAH, escasea
JUEVES, 13 de octubre de 2022 (HealthDay News) — Las personas con un trastorno de déficit de atención e hiperactividad (TDAH) o narcolepsia quizá dependan del medicamento Adderall, pero el fármaco está escaseando, anunció el miércoles la Administraci…
Learn MorePaxlovid, un medicamento para la COVID, podría interactuar con medicamentos cardiacos
JUEVES, 13 de octubre de 2022 (HealthDay News) — Paxlovid, un antiviral para la COVID-19, ha sido un punto de inflexión en la pandemia global, al proteger a los pacientes con un riesgo alto de los efectos más devastadores del coronavirus.Pero el mism…
Learn MoreCOVID Drug Paxlovid Might Interact With Heart Meds
THURSDAY, Oct. 13, 2022 (HealthDay News) — The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects.But Paxlovid can itself pose a risk for people taki…
Learn More